LIPO-IMMUNO TECH, LLC
Biotech · Private
Modified T cell therapies (CAR-T, TCR-engineered, and TIL-based cells) with optimized cytokine expansion protocols for adoptive cell transfer in cancer treatment
- Grants
- $3.0M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2019202020212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Programming Metabolically Fit TILs for Immunotherapy | $224,559 | |
| Federal grant | Department of Health and Human Services · Phase I · Targeting AML Mitochondria by Ceramide | $400,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Increasing Thiols for Improving T cell Immunotherapy | $394,167 | |
| Federal grant | Department of Health and Human Services · Phase II · Programming Metabolically Fit TILs for Immunotherapy | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Programming Metabolically Fit TILs for Immunotherapy | $1,000,000 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1780 | Cartography Biosciences | — | — |
| 1781 | Altos Labs | — | — |
| 1782 | BIOMORPH TECHNOLOGIES LLC | — | — |
| 1783 | LIPO-IMMUNO TECH, LLC | — | — |
| 1784 | Sisu Pharma, Inc. | — | $1.7M |
| 1785 | Function Therapeutics, Inc. | — | — |
| 1786 | SmartLife, Inc. | — | $225K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.